Effects of selective serotonin reuptake inhibitors versus tricyclic antidepressants on cerebrovascular events: A nationwide population-based cohort study

Journal of Clinical Psychopharmacology

Volumn 33, Issue 6, 2013, Pages 782-789

  Lee, Yen Chieh ^a   Lin, Chin Hsien ^b   Lin, Min Shung ^a   Lin, Jou Wei ^b,c   Chang, Chia Hsuin ^b,c   Lai, Mei Shu ^d  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

anxiety; cerebrovascular events; depression; selective serotonin reuptake inhibitors; tricyclic antidepressants

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ESTROGEN; HYPNOTIC AGENT; INSULIN; MOOD STABILIZER; NEUROLEPTIC AGENT; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHRONIC HEPATITIS; CHRONIC KIDNEY DISEASE; CHRONIC LUNG DISEASE; COMPARATIVE STUDY; DEMENTIA; DEPRESSION; DRUG EFFECT; DRUG USE; FEMALE; GASTROINTESTINAL HEMORRHAGE; GOUT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NEUROPATHY; OSTEOARTHRITIS; PEPTIC ULCER; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SLEEP DISORDER; SUBSTANCE ABUSE; TAIWAN; THYROID DISEASE; TREATMENT DURATION; URINE INCONTINENCE;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY DISORDERS; CARBOLINES; COHORT STUDIES; DATABASES, FACTUAL; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; STROKE; TAIWAN;

EID: 84888130776     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31829c970e     Document Type: Article

References (29)

1. Findlay S. Prescription Drug Expenditures in 2001: Another Year of Escalating Costs. Washington, DC: National Institute for Health Care Management Foundation; 2002.
2. Draper B, Berman K. Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly. Drugs Aging. 2008;25:501-519.
3. Andrade C, Sandarsh S, Chethan KB, et al. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry. 2010;71:1565-1575.
4. Singhal AB, Caviness VS, Begleiter AF, et al. Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology. 2002;58:130-133.
5. Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation. 2001;104:1894-1898.
6. Chollet F, Tardy J, Albucher JF, et al. Fluoxetine for motor recovery after acute ischaemic stroke (flame): a randomised placebo-controlled trial. Lancet Neurol. 2011;10:123-130.
7. Pan A, Sun Q, Okereke OI, et al. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA. 2011;306:1241-1249.
8. Ramasubbu R. Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review. J Clin Psychiatry. 2004;65:1642-1653.
9. Swenson JR, Doucette S, Fergusson D. Adverse cardiovascular events in antidepressant trials involving high-risk patients: a systematic review of randomized trials. Can J Psychiatry. 2006;51:923-929.
10. de Abajo FJ, Jick H, Derby L, et al. Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. Br J Clin Pharmacol. 2000;50:43-47.
11. Bak S, Tsiropoulos I, Kjaersgaard JO, et al. Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke. 2002;33:1465-1473.
12. Barbui C, Percudani M, Fortino I, et al. Past use of selective serotonin reuptake inhibitors and the risk of cerebrovascular events in the elderly. Int Clin Psychopharmacol. 2005;20:169-171.
13. Kharofa J, Sekar P, Haverbusch M, et al. Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke. 2007;38:3049-3051.
14. Chen Y, Guo JJ, Li H, et al. Risk of cerebrovascular events associated with antidepressant use in patients with depression: a population-based, nested case-control study. Ann Pharmacother. 2008;42:177-184.
15. Smoller JW, Allison M, Cochrane BB, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the women's health initiative study. Arch Intern Med. 2009;169:2128-2139.
16. Wu CS, Wang SC, Cheng YC, et al. Association of cerebrovascular events with antidepressant use: a case-crossover study. Am J Psychiatry. 2011;168:511-521.
17. Coupland C, Dhiman P, Morriss R, et al. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011;343:d4551.
18. Chien KL, Su TC, Hsu HC, et al. Constructing the prediction model for the risk of stroke in a Chinese population: report from a cohort study in Taiwan. Stroke. 2010;41:1858-1864.
19. Chang CH, Shau WY, Kuo CW, et al. Increased risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study. Stroke. 2010;41:1884-1890.
20. Fiedorowicz JG, He J, Merikangas KR. The association between mood and anxiety disorders with vascular diseases and risk factors in a nationally representative sample. J Psychosom Res. 2011;70:145-154.
21. Sturmer T, Rothman KJ, Avorn J, et al. Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distributionVa simulation study. Am J Epidemiol. 2010;172:843-854.
22. Eklind-Cervenka M, Benson L, Dahlstrom U, et al. Association of candesartan vs losartan with all-cause mortality in patients with heart failure. JAMA. 2011;305:175-182.
23. Molaie M. Serotonin syndrome presenting with migrainelike stroke. Headache. 1997;37:519-521.
24. Maclure M, Mittleman MA. Should we use a case-crossover design? Annu Rev Public Health. 2000;21:193-221.
25. Herrman H, Patrick DL, Diehr P, et al. Longitudinal investigation of depression outcomes in primary care in six countries: the lido study. Functional status, health service use and treatment of people with depressive symptoms. Psychol Med. 2002;32:889-902.
26. Ceylan ME, Alpsan-Omay MH. Bleeding induced by SSRIs. Eur Psychiatry. 2005;20:570-571.
27. Nelva A, Guy C, Tardy-Poncet B, et al. Hemorrhagic syndromes related to selective serotonin reuptake inhibitor (SSRI) antidepressants. Seven case reports and review of the literature. Rev Med Interne. 2000;21:152-160.
28. Warnock JK, Clayton AH, Shaw HA, et al. Onset of menses in two adult patients with Prader-Willi syndrome treated with fluoxetine. Psychopharmacol Bull. 1995;31:239-242.
29. de Abajo FJ, Rodriguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ. 1999;319:1106-1109.